Combination therapy for rheumatoid arthritis in the era of biologicals

HSS Journal

Volumn 2, Issue 1, 2006, Pages 30-41

  Gibofsky, Allan ^a,b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

Combination therapy; Disease modifying antirheumatic drugs; Joint destruction; Rheumatoid arthritis; Tumor necrosis factor antagonists

Indexed keywords

EID: 33748852911     PISSN: 15563316     EISSN: 15563324     Source Type: Journal    
DOI: 10.1007/s11420-005-0133-z     Document Type: Article

References (69)

1. Gabriel SE (2001) The epidemiology of rheumatoid arthritis. Rheum Dis Clin North Am 27:269-281
2. Lee DM, Weinblatt ME (2001) Rheumatoid arthritis. Lancet 358:903-911
3. McQueen FM, Stewart N, Crabbe J et al (1998) Magnetic resonance imaging of the wrist in early rheumatoid arthritis reveals a high prevalence of erosions at four months after symptom onset. Ann Rheum Dis 57:350-356
4. Fuchs HA, Kaye JJ, Callahan LF et al (1989) Evidence of significant radiographie damage in rheumatoid arthritis within the first 2 years of disease. J Rheumatol 16:585-591
5. Felts W, Yelin E (1989) The economic impact of the rheumatic diseases in the United States. J Rheumatol 16:867-884
6. Weinblatt ME (2004) Rheumatoid arthritis: more aggressive approach improves outlook, Clevel Clin J Med 71:409-413
7. van der Heijde DM (1995) Joint erosions and patients with early rheumatoid arthritis. Br J Rheumatol 34(Suppl 2):74-78
8. van der Heijde DM, van Leeuwen MA, van Riel PL et al (1995) Radiographic progression on radiographs of hands and feet during the first 3 years of rheumatoid arthritis measured according to Sharp's method (van der Heijde modification). J Rheumatol 22:1792-1796
9. Stenger AA, Van Leeuwen MA, Houtman PM et al (1998) Early effective suppression of inflammation in rheumatoid arthritis reduces radiographic progression. Br J Rheumatol 37:1157-1163
10. Lard LR, Visser H, Speyer I et al (2001) Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies. Am J Med 111:446-451
11. Boers M, Verhoeven AC, Markusse HM et al (1997) Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet 350:309-318
12. Korpela M, Laasonen L, Hannonen P et al (2004) Retardation of joint damage in patients with early rheumatoid arthritis by initial aggressive treatment with disease-modifying antirheumatic drugs: five-year experience from the FIN-RACo study. Arthritis Rheum 50:2072-2081
13. Kremer JM, Genovese MC, Cannon GW et al (2002) Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 137:726-733
14. Landewe RB, Boers M, Verhoeven AC et al (2002) COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention. Arthritis Rheum 46:347-356
15. O'Dell JR, Haire CE, Erikson N et al (1996) Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications. N Engl J Med 334:1287-1291
16. O'Dell JR, Leff R, Paulsen G et al (2002) Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: results of a two-year, randomized, double-blind, placebo-controlled trial. Arthritis Rheum 46:1164-1170
17. Tugwell P, Pincus T, Yocum D et al (1995) Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. The Methotrexate-Cyclosporine Combination Study Group. N Engl J Med 333:137-141
18. Dougados M, Combe B, Cantagrel A et al (1999) Combination therapy in early rheumatoid arthritis: a randomised, controlled, double blind 52 week clinical trial of sulphasalazine and methotrexate compared with the single components. Ann Rheum Dis 58:220-225
19. Haagsma CJ, van Riel PL, de Jong AJ et al (1997) Combination of sulphasalazine and methotrexate versus the single components in early rheumatoid arthritis: a randomized, controlled, double-blind, 52 week clinical trial. Br J Rheumatol 36:1082-1088
20. Proudman SM, Conaghan PG, Richardson C et al (2000) Treatment of poor-prognosis early rheumatoid arthritis. A randomized study of treatment with methotrexate, cyclosporin A, and intraarticular corticosteroids compared with sulfasalazine alone. Arthritis Rheum 43:1809-1819
21. van den Borne BE, Landewe RB, Goei The HS et al (1998) Combination therapy in recent onset rheumatoid arthritis: a randomized double blind trial of the addition of low dose cyclosporine to patients treated with low dose chloroquine. J Rheumatol 25:1493-1498
22. Enbrel® (etanercept) [package insert] (2004) Thousand Oaks, CA: Amgen Inc. and Wyeth-Ayerst Pharmaceuticals
23. Remicade® (infliximab) [package insert] (2003) Malvern, PA: Centacor Inc.
24. Humira® (adalimumab) [package insert] (2003) North Chicago, IL: Abbott Laboratories
25. Kineret® (anakinra) [package insert] (2002) Thousand Oaks, CA; Amgen Inc.
26. Cohen S, Hurd E, Cush J et al (2002) Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Rheum 46:614-624
27. Fürst DE, Schiff MH, Fleischmann RM et al (2003) Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: Results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis). J Rheumatol 30:2563-2571
28. Klareskog L, van der Heijde D, de Jager JP et al (2004) Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial. Lancet 363:675-681
29. Maini R, St Clair EW, Breedveld F et al (1999) Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal anti body) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial, ATTRACT Study Group. Lancet 354:1932-1939
30. Maini RN, Breedveld FC, Kalden JR et al (2004) Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate. Arthritis Rheum 50:1051-1065
31. Weinblatt ME, Keystone EC, Furst DE et al (2003) Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial. Arthritis Rheum 48:35-45
32. Weinblatt ME, Kremer JM, Bankhurst AD et al (1999) A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med 340:253-259
33. Finals RS, Masi AT, Larsen RA (1981) Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum 24:1308-1315
34. Prevoo ML, van Gestel AM, van T'Hof MA et al (1996) Remission in a prospective study of patients with rheumatoid arthritis. American Rheumatism Association preliminary remission criteria in relation to the disease activity score. Br J Rheumatol 35:1101-1105
35. Klareskog L, van der Heijde D, de Jager JP et al (2004) Clinical outcomes of a double-blind study of etanercept and methotrexate, alone and combined, in patients with active rheumatoid arthritis (TEMPO trial), year 2 results [Abstract]. Ann Rheum Dis 63
36. van der Heijde D, Klareskog L, Pedersen R et al (2004) Assessment of functional status among patients with active rheumatoid arthritis in a double-blind trial of etanercept and methotrexate, alone and combined (TEMPO trial) [Abstract]. Arthritis Rheum 50
37. van der Heijde D, Landewe R, Klareskog L et al (2005) Presentation and analysis of data on radiographic outcome in clinical trials: experience from the TEMPO study. Arthritis Rheum 52:49-60
38. Baumgartner SW, Fleischmann RM, Moreland LW et al (2004) Etanercept (Enbrel) in patients with rheumatoid arthritis with recent onset versus established disease: improvement in disability. J Rheumatol 31:1532-1537
39. St Clair JEW, van der Heijde DM, Smolen JS et al (2004) Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial. Arthritis Rheum 50:3432-3443
40. Smolen J, van der Heijde DM, Emery P et al (2003) Methotrexate naive early rheumatoid arthritis (RA) patients with higher baseline ESR and CRP derive greater radiographic benefit from initiating treatment with a combination of infliximab and methotrexate [Abstract]. Arthritis Rheum 48
41. Breedveld FC, Emery P, Keystone E et al (2004) Infliximab in active early rheumatoid arthritis. Ann Rheum Dis 63:149-155
42. Breedveld FC, Kavanaugh AF, Cohen SB et al (2004) Early treatment of rheumatoid arthritis (RA) with adalimumab (Humira) plus methotrexate vs. adalimumab alone or methotrexate alone: the PREMIER study [Abstract]. Arthritis Rheum 50
43. Keystone EC, Haraoui B, Bykerk VP (2003) Role of adalimumab in the treatment of early rheumatoid arthritis. Clin Exp Rheumatol 21:8198-8199
44. Keystone EC, Kavanaugh A, Sharp J et al (2002) Adalimumab (D2E7), a fully human anti-TNF monoclonal antibody inhibits the progression of structural joint damage in patients with active RA despite concomitant methotrexate therapy [Abstract]. Arthritis Rheum 46
45. Keystone EC, Kavanaugh AF, Sharp JT et al (2004) Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial. Arthritis Rheum 50:1400-1411
46. Cohen SB, Moreland LW, Cush JJ et al (2004) A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate. Ann Rheum Dis 63:1062-1068
47. Fries JF (1999) Safety, cost and effectiveness issues with disease modifying anti-rheumatic drugs in rheumatoid arthritis. Ann Rheum Dis 58(Suppl 1):I86-I89
48. Mullan RH, Bresnihan B (2003) Disease-modifying anti-rheumatic drug therapy and structural damage in early rheumatoid arthritis. Clin Exp Rheumatol 21:8158-8164
49. Goekoop-Ruiterman YPM, De Vries-Bouwstra JK, Zeben DV et al (2004) Treatment strategies in early rheumatoid arthritis: clinical and radiologie outcomes after 2 year follow-up of the BeST Study [Abstract]. Arthritis Rheum 50
50. Grigor C, Capell H, Stirling A et al (2004) Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet 364:263-269
51. Aletaha D, Smolen JS (2002) Effectiveness profiles and dose dependent retention of traditional disease modifying antirheumatic drugs for rheumatoid arthritis. An observational study. J Rheumatol 29:1631-1638
52. Cannella AC, O'Dell JR (2003) Is there still a role for traditional disease-modifying antirheumatic drugs (DMARDs) in rheumatoid arthritis? Curr Opin Rheumatol 15:185-192
53. Motionen T, Hannonen P, Leirisalo-Repo M et al (1999) Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial, FIN-RACo trial group. Lancet 353:1568-1573
54. Wolfe F, Michaud K (2004) Prednisone but not biologies or DMARDs is associated with increased risk of myocardial infarction in persons with RA [ Abstract]. Ann Rheum Dis 63
55. Wolfe F, Michaud K (2004) Rates and risk factors for herpes zoster in patients with rheumatoid arthritis [Abstract]. Ann Rheum Dis 63
56. Wolfe F, Michaud K (2004) Corticosteroids increase the risk of diabetes mellitus in RA and contribute to the risk of myocardial infarction and heart failure [Abstract]. Ann Rheum Dis 63
57. van Everdingen AA, Siewertsz van Reesema DR, Jacobs JW et al (2003) Low-dose glucocorticoids in early rheumatoid arthritis: discordant effects on bone mineral density and fractures? Clin Exp Rheumatol 21:155-160
58. Genovese MC, Martin RW, Fleischmann RM et al (2003) Etanercept (Enbrel) in early erosive rheumatoid arthritis (ERA trial); clinical and radiographie data [Abstract]. Arthritis Rheum 47(Suppl)
59. Singh A, Van der Heijde D, Klareskog L et al (2004) Assessment of treatment satisfaction among patients with active rheumatoid arthritis in a double-blind trial of etanercept and methotrexate, alone and combined (TEMPO trial) [Abstract]. Arthritis Rheum 50(Suppl)
60. Maillefert JF, Combe B, Goupille P et al (2003) Long term structural effects of combination therapy in patients with early rheumatoid arthritis: five year follow up of a prospective double blind controlled study. Ann Rheum Dis 62:764-766
61. Genovese MC, Cohen S, Moreland L et al (2004) Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate. Arthritis Rheum 50:1412-1419
62. Wilske KR, Healey LA (1989) Remodeling the pyramid - a concept whose time has come. J Rheumatol 16:565-567
63. Kremer JM, Weinblatt ME, Bankhurst AD et al (2003) Etanercept added to background methotrexate therapy in patients with rheumatoid arthritis: continued observations. Arthritis Rheum 48:1493-1499
64. Fries JF (1990) Reevaluating the therapeutic approach to rheumatoid arthritis: the "sawtooth" strategy. J Rheumatol, Suppl 22:12-15
65. Sokka TM, Kaarela K, Mottonen TT et al (1999) Conventional monotherapy compared to a "sawtooth" treatment strategy in the radiographic progression of rheumatoid arthritis over the first eight years. Clin Exp Rheumatol 17:527-532
66. Mottonen T, Paimela L, Ahonen J et al (1996) Outcome in patients with early rheumatoid arthritis treated according to the "sawtooth" strategy. Arthritis Rheum 39:996-1005
67. De Vries-Bouwstra JK, Goekoop-Ruiterman YPM, Van Zeben D et al (2004) A comparison of clinical and radiologic outcomes of four treatment strategies for early rheumatoid arthritis: results of the BEST trial [Abstract]. Ann Rheum Dis 63
68. De Vries-Bouwstra JK, Goekoop-Ruiterman YPM, Kerstens PJSM et al (2004) Patient preferences for treatment of newly diagnosed rheumatoid arthritis [Abstract], Ann Rheum Dis 63
69. Breedveld FC et al (June 8-11, 2005) Presented at: EULAR Annual Meeting; Vienna, Austria. Abstract OP0013